Login   |  
Contact   |  

Analysing the rules of proof in China’s first drug patent linkage suit

Wu Xiaohui of Wanhuida Intellectual Property explains a pioneering case heard by the Intellectual Property Court of the Supreme People’s Court and considers its implications for original and generic drug makers

View Full Article

Related Articles

News Feed

Don’t miss it! Join us for World Intellectual Property Day

Blog by Kathi Vidal, Under Secretary of Commerce for Intellectual Property and Director of the USPTOEvery year on April 26,…
Learn More
News Feed

Podcasting’s Copyright Growing Pains

Earlier this week, the New York Times ran a review of a new podcast by Keegan-Michael Key, of the…
Learn More